Anatomically Realistic Neonatal Heart Model for Use in Neonatal Patient Simulators
February 5th, 2019
5.8K views
This protocol describes a procedure for creating functional artificial neonatal heart models by utilizing a combination of magnetic resonance imaging, 3D printing, and injection molding. The purpose of these models is for integration into the next generation of neonatal patient simulators and as a tool for physiological and anatomical studies.
Overview
This protocol describes a procedure for creating functional artificial neonatal heart models using magnetic resonance imaging, 3D printing, and injection molding. These models are intended for integration into neonatal patient simulators and for physiological and anatomical studies.
Key Study Components
Area of Science
- Neonatology
- Biomedical Engineering
- Cardiovascular Physiology
Background
- Understanding cardiac output during chest compressions is crucial in neonatology.
- Current models lack flexibility while maintaining anatomical realism.
- Advancements in imaging and modeling techniques can enhance neonatal care.
- Magnetic resonance imaging provides detailed anatomical data for model creation.
Purpose of Study
- Create realistic neonatal heart models for simulation.
- Facilitate physiological and anatomical studies.
- Improve training for medical professionals in neonatal resuscitation.
Methods Used
- Utilization of magnetic resonance imaging to capture heart anatomy.
- 3D printing to fabricate heart models based on MRI data.
- Injection molding techniques for model flexibility.
- Editing Masks tool in software for precise heart area selection.
Main Results
- Successful creation of flexible heart models without loss of realism.
- Demonstrated ability to simulate cardiac output during compressions.
- Enhanced training tools for neonatal care professionals.
- Potential for further research in neonatal physiology.
Conclusions
- The developed models can significantly aid in neonatal training and research.
- Combining imaging and modeling techniques offers new possibilities in medical simulations.
- Future studies may expand on the applications of these models in clinical settings.
Frequently Asked Questions
What is the main advantage of using this technique?
The main advantage is the creation of a flexible heart model that maintains anatomical realism.
Who is demonstrating the procedure?
Jasper Sterk, a technician from our laboratory, is demonstrating the procedure.
What software is used for processing MRI images?
An appropriate processing software program that supports Digital Imaging and Communications in Medicine files is used.
How does this model contribute to neonatal care?
It provides a realistic training tool for medical professionals, enhancing their skills in neonatal resuscitation.
What are the potential applications of these heart models?
They can be used for training, physiological studies, and improving neonatal patient simulators.
Can this method be applied to other areas of research?
Yes, the techniques may be adapted for other anatomical models and research areas.
Executive Industry Relevance
High-fidelity anatomical modeling of neonatal hearts enables quantitative assessment of cardiac output during simulated interventions, addressing a critical gap in translational device and physiological research. Integrating MRI-based 3D printing and flexible molding supports the development of advanced patient simulators, enhancing predictive confidence in neonatal resuscitation workflows. This capability positions R&D teams to better evaluate device-tissue interactions and optimize training platforms for early-stage innovation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic interrogation of cardiac output generation during simulated chest compressions.
- Supports functional validation of device-tissue interactions in anatomically accurate neonatal systems.
- Facilitates biological de-risking by providing physiologically relevant testbeds for intervention studies.
Screening & Assay Development
- Prepares validated, reproducible heart models for downstream device or intervention screening.
- Standardizes anatomical and physiological parameters for quantitative output measurement.
- Enables scalable production of test systems for comparative evaluation of clinical techniques.
Translational & Preclinical Research
- Aligns simulated outputs with disease-relevant neonatal physiology for translational continuity.
- Supports risk-adjusted advancement of new devices or protocols by providing predictive, reproducible models.
- Bridges discovery-stage modeling with preclinical validation in neonatal care research.
Pipeline & Workflow Integration
This modeling approach integrates into the discovery-to-preclinical continuum, supporting hypothesis testing, device screening, and translational research in neonatal cardiovascular systems.
- Discovery Biology: Provides a platform for hypothesis-driven testing of cardiac interventions and output quantification.
- Screening: Delivers reproducible, anatomically accurate models for standardized device or technique evaluation.
- Analytics: Enables quantitative measurement of cardiac output and other physiological readouts during simulated procedures.
- Translational Research: Ensures continuity between in vitro simulation and preclinical validation in neonatal models.
- Enterprise Reuse: Offers a reusable modeling capability adaptable to other organ systems or device development pipelines.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neonatal intervention studies.
- Operational Value: Standardizes model production for reproducibility and scalability across R&D teams.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling early-stage de-risking.
- Portfolio Impact: Supports risk-adjusted prioritization of device and protocol development in neonatal care.
Implementation Considerations
- Requires expertise in MRI segmentation, 3D modeling, and flexible material processing.
- Demands access to high-resolution imaging, 3D printing, and injection molding infrastructure.
- Necessitates cross-team standardization of anatomical and physiological parameters.
- Adaptation to other organ systems may require protocol optimization for geometry and material properties.
- Model fidelity and reproducibility depend on imaging quality and material selection.
Biopharma FAQs
Why does null hypothesis testing matter for cardiac output measurement?
Null hypothesis testing enables objective evaluation of whether simulated chest compressions generate statistically significant cardiac output in the neonatal heart model. This supports rigorous validation of intervention efficacy and informs early-stage device or protocol development decisions.
How does independent variable isolation fit the 3D heart modeling workflow?
Isolating variables such as compression force or anatomical configuration within the heart model allows R&D teams to systematically assess their impact on cardiac output. This approach enhances mechanistic clarity and supports reproducible, hypothesis-driven experimentation.
What do quantitative dependent variable measurements enable in simulator studies?
Quantitative measurement of outputs like cardiac flow during simulated compressions provides actionable data for comparing intervention techniques and optimizing simulator design. These metrics underpin predictive modeling and translational research continuity.
Why are replication requirements critical for cross-functional neonatal simulator development?
Replication ensures that heart models and output measurements are consistent across teams and studies, supporting collaborative development and standardization of neonatal simulation platforms. This reliability is essential for enterprise-scale R&D and regulatory alignment.
What statistical analysis capabilities are required before implementing cardiac output monitoring?
Robust statistical tools are needed to analyze output data, assess variability, and determine significance thresholds for simulated interventions. These capabilities enable confident interpretation of results and guide further model or protocol refinement.
